<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00827723</url>
  </required_header>
  <id_info>
    <org_study_id>251/08</org_study_id>
    <nct_id>NCT00827723</nct_id>
  </id_info>
  <brief_title>Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma</brief_title>
  <official_title>Makuuchi Versus Barcelona Clinic of Liver Cancer Criteria in Cirrhotic Patients With Hepatocellular Carcinoma. Does Etiology of Cirrhosis Influence the Relationship Between the Portal Pressure and Quantitative Tests of Liver Function?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Lausanne Hospitals</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Lausanne Hospitals</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the investigators' study is to elucidate the relationship between a functional
      liver test (e.g., ICG) and the PREOPERATIVE value of portal hypertension in the patients with
      impaired liver function from alcoholic and non-alcoholic aetiologies. Alcoholic and viral
      cirrhosis present important differences in terms of cellular mechanisms responsible for the
      disease progression with a distinct and unique gene expression pattern that regulates the
      type of inflammatory response. These differences probably influence the hepatic functional
      reserve and the onset of portal hypertension at a comparable clinical and biological level of
      derangement and the investigators may expect significant differences in the recovery from
      hepatectomy.

      The investigators' hypothesis is that at a comparable ICGR-15 rate non-viral cirrhotic liver
      presents higher portal pressure values and the investigators also argue that alcoholic
      cirrhotic patients would tolerate a larger hepatic resection than would viral cirrhotic do.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2009</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>concordance rate between ICGR-15 and Portal Pressure values in patients with resectable HCC and cirrhosis Child A from alcoholic and non-alcoholic origin.</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative liver failure.</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Carcinoma, Hepatocellular</condition>
  <condition>Alcoholic Cirrhosis</condition>
  <condition>Viral Cirrhosis</condition>
  <condition>Postoperative Hepatic Failure</condition>
  <arm_group>
    <arm_group_label>Alcoholic</arm_group_label>
    <description>Alcoholic cirrhotic patient with resectable hepatocellular carcinoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Viral</arm_group_label>
    <description>Viral cirrhotic patient with resectable hepatocellular carcinoma</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Community sample
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  resectable or amenable to resection HCC in cirrhotic child A patients of alcoholic or
             viral etiology

        Exclusion Criteria:

          -  cirrhosis Child-Pugh B

          -  absence of patient consent

          -  psychiatric pathology
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diana Michele, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHUV University Hospital of Lausanne</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Halkic Nermin, PD</last_name>
    <role>Study Director</role>
    <affiliation>CHUV University Hospital of Lausanne</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Demartines Nicolas, Professeur</last_name>
    <role>Study Chair</role>
    <affiliation>CHUV University Hospitals of Lausanne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diana Michele, MD</last_name>
    <phone>0041213142369</phone>
    <email>michelediana@virgilio.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Halkic Nermin, PD MER</last_name>
    <phone>0041213142248</phone>
    <email>Nermin.Halkic@chuv.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Vaudois (CHUV)</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <zip>1005</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana Michele, MD</last_name>
      <phone>+41213142369</phone>
      <phone_ext>0793618939</phone_ext>
      <email>michelediana@virgilio.it</email>
    </contact>
    <contact_backup>
      <last_name>Halkic Nermin, PD</last_name>
      <phone>+41213142248</phone>
      <email>Nermin.Halkic@chuv.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Diana Michele, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Halkic Nermin, PD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Yamazaki S, Takayama T. Surgical treatment of hepatocellular carcinoma: evidence-based outcomes. World J Gastroenterol. 2008 Feb 7;14(5):685-92. Review.</citation>
    <PMID>18205256</PMID>
  </reference>
  <reference>
    <citation>Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, Takayama T, Makuuchi M. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg. 2003 Nov;138(11):1198-206; discussion 1206.</citation>
    <PMID>14609867</PMID>
  </reference>
  <reference>
    <citation>Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y, Kubota K, Zucchi A. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg. 1999 Sep;134(9):984-92.</citation>
    <PMID>10487594</PMID>
  </reference>
  <reference>
    <citation>Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003 Dec 6;362(9399):1907-17. Review.</citation>
    <PMID>14667750</PMID>
  </reference>
  <reference>
    <citation>Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, Visa J, Bru C, Rod√©s J. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996 Oct;111(4):1018-22.</citation>
    <PMID>8831597</PMID>
  </reference>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 22, 2009</study_first_submitted>
  <study_first_submitted_qc>January 22, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 23, 2009</study_first_posted>
  <last_update_submitted>January 27, 2016</last_update_submitted>
  <last_update_submitted_qc>January 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Lausanne Hospitals</investigator_affiliation>
    <investigator_full_name>Nicolas DEMARTINES</investigator_full_name>
    <investigator_title>professor of surgery</investigator_title>
  </responsible_party>
  <keyword>Hepatic functional reserve</keyword>
  <keyword>Hepatocellular carcinoma (HCC)</keyword>
  <keyword>Indocyanine Green retention rate at 15 minutes (ICG-R15')</keyword>
  <keyword>Portal Pressure (PP)</keyword>
  <keyword>Hepatic Portal Venous Gradient (HPVG)</keyword>
  <keyword>Alcoholic and Viral Cirrhosis</keyword>
  <keyword>Makuuchi criteria</keyword>
  <keyword>Barcelona Clinic of Liver Cancer (BCLC)</keyword>
  <keyword>Hepatic resection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Liver Failure</mesh_term>
    <mesh_term>Liver Cirrhosis, Alcoholic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

